title: Why should 1 gram of ceftriaxone monotherapy be considered as a therapeutic option in gonococcal sexually transmitted diseases?
authors.affiliation: Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, Groupe Hospitalier Paris Ile de France Ouest, Garches, France. Electronic address: benjamin.davido@aphp.fr.
authors.forename: B
authors.initials: B
authors.lastname: Davido
authors.affiliation: Pharmacie Hospitalière, Hôpital Universitaire Raymond-Poincaré, Groupe Hospitalier Paris Ile de France Ouest, Garches, France.
authors.forename: F
authors.initials: F
authors.lastname: Bouchand
authors.affiliation: Pharmacie Hospitalière, Hôpital Universitaire Ambroise Paré, Groupe Hospitalier Paris Ile de France Ouest, Boulogne Billancourt, France.
authors.forename: T
authors.initials: T
authors.lastname: Tritz
authors.affiliation: Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, Groupe Hospitalier Paris Ile de France Ouest, Garches, France.
authors.forename: S
authors.initials: S
authors.lastname: Makhloufi
mesh_terms: D061605:Administration, Intravenous; D017963:Azithromycin / Q000009:adverse effects / Q000191:economics; D002443:Ceftriaxone / Q000008:administration & dosage* / Q000191:economics / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D005060:Europe; D006069:Gonorrhea / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D017410:Practice Guidelines as Topic; D012749:Sexually Transmitted Diseases / Q000188:drug therapy* / Q000191:economics; D014481:United States
chemical_list: D002443:Ceftriaxone; D017963:Azithromycin
keywords: Ceftriaxone; Gonococcus; Guidelines; Monotherapy; Sexually transmitted diseases; Urethritis